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Apathy is considered to be a core feature of Parkinson’s disease (PD) and has
been associated with a variety of states and symptoms of the disease, such as
increased severity of motor symptoms, impaired cognition, executive dysfunction
and dementia. Apart from the high prevalence of apathy in PD, which is estimated
to be about 40%, the underlying pathophysiology remains poorly understood and
current treatment approaches are unspecific and proved to be only partially effective.
In animal models, apathy has been sub-optimally modeled, mostly by means of
pharmacological and stress-induced methods, whereby concomitant depressive-like
symptoms could not be ruled out. In the context of PD only a few studies on
toxin-based models (i.e., 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)) claimed to have determined apathetic symptoms in animals.
The assessment of apathetic symptoms in more elaborated and multifaceted genetic
animal models of PD could help to understand the pathophysiological development
of apathy in PD and eventually advance specific treatments for afflicted patients.
Here we report the presence of behavioral signs of apathy in 12 months old
mice that express only ∼5% of the vesicular monoamine transporter 2 (VMAT2).
Apathetic-like behavior in VMAT2 deficient (LO) mice was evidenced by impaired
burrowing and nest building skills, and a reduced preference for sweet solution in
the saccharin preference test, while the performance in the forced swimming test
was normal. Our preliminary results suggest that VMAT2 deficient mice show an
apathetic-like phenotype that might be independent of depressive-like symptoms.
Therefore VMAT2 LO mice could be a useful tool to study the pathophysiological
substrates of apathy and to test novel treatment strategies for apathy in the
context of PD.
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INTRODUCTION
About 40% of all patients with Parkinson’s disease (PD) are estimated to suffer from apathy
(den Brok et al., 2015), a behavioral syndrome that is characterized by loss of or diminished
motivation for goal-directed actions, affecting behavior, emotions and cognition (Robert
et al., 2009; Pagonabarraga et al., 2015). Apathy in PD is of clinical relevance, because
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of its association with poorer prognosis and raised caregiver
burden (Pedersen et al., 2009b; Schiehser et al., 2013), and
because it is often a chronic condition which is difficult to treat
(van Reekum et al., 2005; Benito-León et al., 2012; Skorvanek
et al., 2013).
Apathy in PD is highly comorbid with depression and can
easily be misinterpreted as such (van Reekum et al., 2005).
However, the progression of apathy in PD is rather linked to the
progression of the typical motor-symptoms than with depression
(Zahodne et al., 2012), probably indicating independent roots
for both conditions in the context of PD. In this line, apathy
might be associated with a hypodopaminergic state in the
mesocorticolimbic pathway in PD (Czernecki et al., 2008;
Pagonabarraga et al., 2015), although lesions and neuroimaging
studies suggest the dysfunction of frontal-subcortical circuits,
especially those linking the ventromedial prefrontal cortex to
related regions in the basal ganglia, also to be relevant for the
development of apathy (van Reekum et al., 2005; Levy and
Czernecki, 2006; Chase, 2011; Santangelo et al., 2013; Robert
et al., 2014).
Despite the increasing awareness on the importance of
apathy as a comorbid condition in PD, specific treatment
strategies for patients are lacking. Furthermore, assessment
tests in rodents for preclinical study of apathy are poorly
developed. Since apathetic-like symptoms in rodents might be
mistaken for depressive-like signs, tests to distinctively assess
those symptoms would be favorable. We therefore selected
three established behavioral tests, the burrowing test, the nest
building test and the saccharin preference test, which we
hypothesize might measure apathetic-like symptoms in mice.
The burrowing behavior probably constitutes a motivation-
dependent behavioral need, which is based in the behavior
itself and not on its functional consequences (Sherwin et al.,
2004). This finding is akin to human apathetic patients, who
show drastically reduced self-generated voluntary and purposeful
behaviors (Levy and Dubois, 2006). Moreover, it is suggested
that burrowing represents a measure of well-being (Jirkof, 2014)
and a murine form of the ability to perform goal-directed
‘‘activities of daily living’’, like taking care of oneself and others
(Deacon, 2009; Jirkof, 2014). The same has been suggested
for the nest building behavior (Deacon, 2009; Jirkof, 2014).
Because dysfunction of motivation is a core feature of apathy
(Robert et al., 2009) and decreased well-being and goal-directed
activities are also significantly impaired in patients with apathy
(Marin, 1991), we speculate that decreased performance in
these tests could possibly reflect an apathetic-like phenotype
in mice. The preference for sweet solutions has been proposed
to measure anhedonia (Malatynska et al., 2012; Overstreet,
2012; Klein et al., 2015), which is not only a feature of
depression, but also of apathy (Pagonabarraga et al., 2015)
and has been shown to be more closely associated with
apathy than with depression in PD (Kaji and Hirata, 2011).
To differentiate apathetic-like from depressive-like symptoms
we used the forced swimming test, a widely used test to
assess signs of depression in rodents (Borsini and Meli, 1988;
Bourin et al., 1998; Cryan et al., 2005; Petit-Demouliere et al.,
2005).
In this line, selecting tests that measure dopamine-modulated
goal-directed and/or reward-related behaviors is key to
reliably assess apathy in animals. For instance, it has been
shown that nest building behavior in rodents is disrupted
by the administration of dopamine receptor antagonists
and restored by application of agonists (Giordano et al.,
1990; Silva et al., 2001) or gene therapy for dopaminergic
restoration in dopamine-deficient mice (Szczypka et al.,
2001). Moreover, the impaired nest building performance in
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned
C57Bl/6 mice (Sedelis et al., 2000; Hofele et al., 2001), and the
consequential improvement after L-DOPA injections (Sager
et al., 2010), emphasize dopaminergic involvement in the test.
In the same manner, it has been reported that dopaminergic
systems are involved in the preference for a sweetened solution
(Muscat and Willner, 1989; Brenes and Fornaguera, 2008),
therefore allowing to hypothesize that the saccharin preference
test might reflect apathetic-like symptoms by impairments in the
reward system.
Here we aim at characterizing an established murine model
of PD in terms of apathetic- and possible depressive-like
phenotypes in order to potentially provide a novel biological tool
for the study of apathy in the context of PD. Thus, we used
12 months old vesicular monoamine transporter 2 (VMAT2)
deficient mice (VMAT2 LOmice or LOmice), a well- established
animal model of PD (Mooslehner et al., 2001; Caudle et al.,
2007; Taylor et al., 2009), to test for an apathy-like phenotype
by means of the burrowing test, nest building test and saccharin
preference test, and for a possible depressive-like phenotype by
means of the forced swimming test. Our preliminary results
suggest that for 12 months VMAT2 LO mice show a rather
apathetic than depressive-like phenotype, therefore becoming a
potential tool for the study of neurobiological substrates and
specific treatments for apathy in the context of PD.
MATERIALS AND METHODS
Animals
In this study we tested two different mouse genotypes. The first
group consisted of VMAT2 deficient mice (LO, n = 15) on a
C57Bl/6J background (Mooslehner et al., 2001; Caudle et al.,
2007; Taylor et al., 2009), originally obtained by embryonic
recovery from Jackson laboratories with the kind permission of
Prof. Dr. G. Miller (Emory University, Atlanta, GA, USA) and
bred in-house (BZL, University Hospital, Zurich, Switzerland).
The second group consisted of wild-type control C57Bl/6 mice
(WT, n = 19) either littermates or obtained from a supplier
(Janvier Labs, Le Genest-Saint-Isle, France). All mice were male
and their mean age at the start of the experiment was 371 days
with a standard deviation of 8 days and a range of 355–380 days.
We single-caged the mice in clear-transparent Eurotype II L
plastic cages (Indulab AG, Gams, Switzerland), with food and
water available ad libitum 7 days prior to behavioral testing. The
room temperature was maintained constantly at 21–22◦C, and
on a 12 h light-dark cycle starting at 8.00 or 9.00 a.m., according
to season. Both animal housing conditions and experimental
manipulations were approved by the Ethics Committee of the
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Cantonal Veterinary Office of Zurich, Switzerland under license
no. ZH 205/2012, and were in accordance with Swiss Animal
Protection Ordinance.
Genotyping and PCR
We permanently marked VMAT2 LO mice with ear punches
following a standard mice numbering procedure. We then
used the ear biopsies to extract genomic DNA (DNeasyr
Blood and Tissue Kit, Qiagen, Germany) and performed the
genotyping by polymerase chain reaction (PCR) experiments.
Genotypes were further confirmed fromDNA extracted from tail
samples taken immediately prior to the sacrifice of the animals.
Briefly, the PCR protocol was performed with the forward
primer Forward_WT (5′-GCGAATATTCCAGTCCTCCA-
3′) and the reverse primer Rev_WT (5′-
CAGGCAACACCAGAAACAAT-3′) for VMAT2 WT
and Rev_KO (5′-GGAAAGTGAGCCACCATGTAG-3′) for
VMAT2 LO. Amplification was performed in a 25 µL reaction
mixture with 9.5 µL nuclease free water, 1 µL forward primer
(10 µM), 0.5 µl of each reverse primer (10 µM), 12.5 µl GoTaq
green master mix (Promega, Madison, WI, USA) and 1 µL of
DNA using a standard thermocycler (TProfessional; Biometra,
Göttingen, Germany). PCR cycle started with 4 min of initial
denaturation at 94◦C, followed by 25 repeated cycles of 1 min
denaturation at 94◦C, 1.5 min annealing at 57◦C and 1 min
of extension at 72◦C, and ended with 7 min of final extension
at 72◦C. PCR products were stained with GelRed (Biotium,
Hayard, CA, USA) separated with electrophoresis at 150 V for
1 h in a 3% agarose gel (w/v) in 1 × TAE buffer and visualized
under UV light.
Behavioral Testing
Burrowing Test
The burrowing test has been proven to be sensitive to brain
lesions, infections, pharmacological agents, pain, models of
inflammatory bowel disease, schizophrenia, anxiety, Alzheimer’s
Disease and other pathological states (Deacon, 2006b; Jirkof,
2014). Burrowing behavior is thought to constitute a motivation-
dependent behavioral need (Sherwin et al., 2004) that might
represent a murine form of the ability to perform ‘‘activities
of daily living’’ (Deacon, 2009; Jirkof, 2014). The burrowing
test measures how much an animal burrows, i.e., how much
burrowing material (e.g., food pellets) of a filled container
is removed during a defined time window. Mice achieve
the removal by kicks and coordinated hind- and forelimb
movements. This burrowing behavior is quantified by comparing
the amount of burrowing material in the container at the onset
of the experiment with the amount left over after the experiment.
We adapted the test to the description of previously published
records (Deacon, 2006a; Jirkof, 2014). Briefly, we habituated
all mice to the burrowing setup prior to the experiment and
performed the test in the home cage. We placed two 250 mL
plastic bottles (150 mm × 55 mm, l × Ø) that served as
burrowing containers and placed them in the left and right
corners of the cages’ posterior walls. In each cage, we filled one
container (alternatively left or right) with∼140 g of regular food
pellets that served as burrowing material. The other container
was left empty and served as shelter. We measured the weight
of the filled container before the test (at 18:00 h), 2 h later (2 h;
20:00 h) and on the next morning (overnight; 9:00 h). After the
2 h-measurement, the burrowing container was refilled up to the
same weight as at test onset. Percentage of pellets burrowed was
calculated separately for the 2 h and the overnight measurement.
This was done by subtracting the weight of burrowing container
after the test from the weight of burrowing container at test start.
Absolute values were then transformed in percentages, resulting
in the percentage burrowed for the 2 h and the overnight period.
Initially, we tested n = 19 WT and n = 15 LO mice. After
inspection of the data, good and poor burrowers of each genotype
and for each test period were identified by median split in order
to analyze the groups separately. Thus, proficient burrowers were
defined as those presenting burrowing rates≥ the group median:
2 h period 85% for WT and 73% for LO, overnight period
100% for WT and LO; and poor burrowers were the animals
below the median of the respective group. Two outliers were
identified using the Grubbs’ test and excluded from the analysis:
1 LO mouse from the 2 h poor burrowers population and 1 WT
mouse from the 24 h poor burrowers population. Finally, we
performed 2-sided, unpaired t-tests comparing: (1) n = 19 WT
and n = 15 LO mice in both periods (whole population); (2)
n = 10 WT and n = 8 LO mice for the 2 h period, and n = 10 WT
and n= 8 LOmice for the overnight period (proficient burrowers);
and (3) n = 9 WT and n = 6 LO mice for the 2 h period, and
n = 8 WT and n = 7 LO mice for the overnight period (poor
burrowers).
Nest Building Test
The nest building test has been used to detect deficits in nest
quality in murine models of PD, Alzheimer’s Disease, brain
lesions, obsessive-compulsive disorders, autism, pain, prion
infection and other diseases (Greene-Schloesser et al., 2011;
Deacon, 2012; Jirkof et al., 2013). Similar to apathy (Czernecki
et al., 2008; Santangelo et al., 2013; Thobois et al., 2013), nest
building behavior has been shown to depend on dopaminergic
pathways (Giordano et al., 1990; Szczypka et al., 2001; Sager
et al., 2010; Paumier et al., 2013) and is assumed to represent
the ability to perform ‘‘activities of daily living’’ (Deacon, 2009;
Jirkof, 2014). The quality of mice nests can be quantified with
the nest building test (Deacon, 2006b), simply by providing
nesting material (e.g., a compressed cotton piece) overnight
and rating the nest quality on the next morning. Additionally,
the weight of shredded nesting material can be used as a
semi-independent measure of nest complexity (Deacon, 2012).
Prior to the experiment, we habituated the mice to the nesting
material and performed the nest building test in the home
cage, based on previous reports (Deacon, 2006b; Jirkof, 2014).
Briefly, we introduced a cotton Nestlet (5 cm × 5 cm, Indulab
AG, Gams, Switzerland) in the center of the cage’s frontal
wall. In the following morning, we weighed the amount of
untorn Nestlet, calculated the difference in weight to the Nestlet
at test onset and expressed the value of material shredded
in percentage. Also in the next morning, we scored the nest
quality on a 5-point scale; 1: Nestlet > 90% intact (Nestlet not
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noticeably touched); 2: Nestlet 50–90% intact (Nestlet partially
torn up); 3: Nestlet < 50% intact (Nestlet mostly shredded, but
no identifiable nest site); 4: Nestlet < 10% intact (identifiable,
but flat nest) and 5: Nestlet < 10% intact (a ‘‘near’’ perfect
nest). Where criteria for the amount of shredded Nestlet and
the nest quality did not agree (e.g., a ‘‘near’’ perfect nest with a
Nestlet > 50% intact), the difference was split (Deacon, 2012).
This way the nest scorings can also have half values. From the
n = 19 WT and n = 15 LO mice tested, we identified active
and inactive nesters and separated them by median-split. Thus,
animals displaying naturally poor or inactive nesting activity
(nesters below the median of the groups for both parameters
assessed, i.e., nest score: 4 points for WT and 3 points for LO
mice; percentage of Nestlet torn: 91% for WT and 51% for LO
mice) were separated from active or good nesters. Finally, we
performed 2-sided, unpaired t-tests comparing: (1) n = 19 WT
and n = 15 LO mice for both parameters (whole population);
(2) n = 10WT and n = 10 LOmice for the nest score and n = 9WT
and n = 8 LO for the percentage of Nestlet torn (active nesters);
and (3) n = 9 WT and n = 5 LO mice for the nest score and
n = 10 WT and n = 7 LO for the percentage of Nestlet torn
(inactive nesters).
Saccharin Preference Test
The saccharin preference test has been proposed to measure
symptoms of anxiety, depression and anhedonia (lack of
pleasure; Forbes et al., 1996; Brenes and Fornaguera, 2008;
Malatynska et al., 2012; Klein et al., 2015). However, it is
highly likely that the saccharin preference test rather measures
apathetic-like symptoms. It has been shown that the preference
for sweetened solutions in rodents drastically depends on the
dopaminergic system (Muscat and Willner, 1989; Szczypka
et al., 2001; Brenes and Fornaguera, 2008; Malatynska et al.,
2012), which is also a key player in the pathology of apathy
(Pedersen et al., 2009a,b; Zahodne et al., 2012). The preference
for sweet solutions can be measured by means of the two-bottle
preference test (Bachmanov et al., 2001; Sclafani, 2006), by
providing one bottle with sweetened solution, and one bottle
filled with water. After a defined time window, the intake of
each solution is calculated and the preference for the sweet
solution is expressed as a ratio in favor of the sweet solution.
In the present study we tested the preference for saccharin,
also a sweet compound, and based the protocol on previous
reports (Bachmanov et al., 1996; Sclafani, 2006). First, we
habituated the mice with the test cages, bottles and their
content for 48 h prior to the experiment (Sclafani, 2006). The
test took place in clear-transparent Eurotype III test cages
(425 mm × 266 mm × 155 mm, l × w × h; Indulab AG, Gams,
Switzerland). The cages were equipped with sawdust, regular nest
building tissue, a bottle of water, a bottle of freshly prepared 0.1%
w/w saccharin solution (Sigma-Aldrich Chemie GmbH, Buchs,
Switzerland) and regular food ad libitum. Both tap water and
saccharin solution were provided in 100 mL plastic drinking
bottles with an 8 mm diameter, 2 mm opening and 6.5 cm length
stainless steel sipper spout (Techniplast S.p.A., Buguggiate, Italy).
We introduced the previously weighed bottles into the test cages
and weighed them again 24 h later. We calculated the absolute
liquid intake separately for water and saccharin solution by
subtracting the weight of the bottles after the test from the
weights of the bottles prior to the test. For further analyses, we
transformed the weight values into the corresponding volumes
and normalized the volumes by the body weight of the respective
mice. The saccharin preference ratio was calculated by dividing
the volume of saccharin solution drunk by the volume of total
liquid consumption. Out of n = 19WT and n = 15 LOmice tested,
one data point was excluded from the analysis due to leakage
of one of the testing bottles. We analyzed the data by a 2-sided,
unpaired t-test for each variable, incorporating totally n = 19WT
and n = 14 LO animals.
Forced Swimming Test
The forced swimming test is widely used to assess depressive-like
symptoms in rodents (Porsolt et al., 1979). In the forced
swimming test, mice are forced to swim in a container filled
with water that does not allow for escape. Normally they
rapidly stop attempts to escape and become immobile, a
behavior that is quantified as the time spent immobile, which
is typically interpreted as behavioral despair and a measure
of depressive-like behavior in rodents. We slightly adapted
the forced swimming test as described previously (Porsolt
et al., 1979; Taylor et al., 2009). Briefly, we tested the mice
in batches of 3–4 animals at a time and their swimming
activity was recorded during 4 min from above by an infrared
camera. Raw data was acquired and analyzed with the software
EthoVision XT 9.0 (Noldus Information Technology GmbH,
Oberreifenberg, Germany) on a standard PC. The experimental
setup consisted of a set of four square areas (each 53 cm× 53 cm)
separated by wooden walls, allowing testing of four mice
simultaneously. Immediately before testing, a 2000 mL glass
beaker (19 cm × 13 cm, h × Ø) was placed in each area, and
filled with 1500 mL fresh (25◦C) tap water. Swimming behavior
was recorded for 6 min, but only the last 4 min were subjected to
analysis (Taylor et al., 2009).We defined the time spent immobile
as a floating behavior with a max speed of 3 cm/s, a value that
became apparent of being a threshold value for active swimming
behavior by detailed analysis of movement tracking. We tested a
total of n = 19 WT and n = 15 LO mice. After inspection of the
data, good and poor swimmers of each genotype were identified
by median split in order to analyze the sub-groups separately.
Thus, proficient swimmers were defined as those presenting
immobility times≤ the groupmedian: 192 s forWT and 194 s for
LO. Finally, we performed 2-sided, unpaired t-tests comparing:
(1) n = 19 WT and n = 15 LO mice (whole population); (2) n = 9
WT and n = 7 LOmice (proficient swimmers); and (3) n = 10WT
and n = 8 LO mice (poor swimmers).
RESULTS
VMAT2 Deficient Mice Present Impaired
Performance in Goal-Directed and
Reward-Related Behavioral Tasks
To evaluate whether goal-directed behaviors were affected in
VMAT2 mutant animals, we tested LO mice and their WT
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FIGURE 1 | Decreased burrowing activity in vesicular monoamine transporter 2 (VMAT2) deficient mice. Burrowing activity was determined 2 h (A–C)
and one night (D–F) after the test start in both LO mice and their WT controls. No differences were found in the whole (n = 19 WT, n = 15 LO; A,D) or proficient
(n = 10 WT, n = 8 LO; B,E) burrower populations. In the poor burrower population, the percentage of burrowed material of LO mice was not significantly different
from WT mice (n = 9 WT, n = 6 LO; §p = 0.055; C) after 2 h. However, the percentage of burrowed material was significantly reduced in LO mice (n = 8 WT, n = 7 LO;
∗p < 0.05; F) for the overnight period. Bars indicate the mean of the groups and error bars indicate the S.E.M. § Indicates a non-significant trend.
controls in two different tasks, the burrowing test and the
nest building test. First, we performed the burrowing test
(Figure 1), by which we measured the amount of burrowed
material during two different periods of time, 2 h (Figures 1A–C)
and overnight (Figures 1D–F) for the whole population tested
(Figures 1A,D), the proficient burrowers (Figures 1B,E) and
the poor burrowers (Figures 1C,F). Our results showed no
significant difference between LO and WT mice within the
whole population in the percentage of burrowed food pellets
2 h or 24 h after the test start. In an attempt to reduce the
variability and unmask possible differences in subpopulations
of animals classified on the basis of their performance, we
then identified and separated proficient from poor burrowers
in both time periods. In the analysis of the good burrowers no
significant differences were observed between genotypes at any
test time point. However, in the analysis of the poor burrowers,
we observed a non-significant trend towards reduced burrowing
performance in LOmice at 2 h (2-sided, unpaired t-tests; 2 hWT
vs. LO §p = 0.055). And we determined a significantly reduced
percentage of material burrowed in LOmice, as compared toWT
animals (2-sided, unpaired t tests; 24 h WT vs. LO ∗p < 0.05)
in the overnight measure. We then performed the nest building
test (Figure 2), in which we assessed the nesting activity by
measuring the amount of nesting material used (percentage of
Nestlet torn, Figures 2A–C) and rated the quality of the nests
(rating scores from 1 to 5 points, Figures 2D–F) for the whole
population (Figures 2A,D), the active nesters (Figures 2B,E)
and the inactive nesters (Figures 2C,F). Our results showed no
significant differences for both the whole population and the
inactive nesters groups for both tested parameters. However,
we observed both significantly lower percentage of Nestlet torn
and nest rating in LO mice, as compared to WT controls, in
the active nesters group (2-sided, unpaired t-tests; percentage
of Nestlet torn WT vs. LO ∗p < 0.05, nest ratings WT vs. LO
∗∗p< 0.01).
To explore the reward-related behavioral performance in
VMAT2 mutant animals, we subjected LO and WT mice to the
saccharin preference test (Figure 3). In the SPT we measured
water (Figure 3A), saccharin (Figure 3B) and total liquid intake
(Figure 3C) in respect to body weight, as well as the saccharin
preference ratio (Figure 3D) in both genotypes. Our results
showed similar water intake of LO and WT mice. However, total
liquid intake, saccharin intake and the saccharin preference ratio
were significantly reduced in LO animals, as compared to their
WT controls (2-sided, unpaired t-tests; water intake WT vs. LO
p > 0.05, saccharin intake WT vs. LO ∗∗p < 0.01, total liquid
intake WT vs. LO ∗p < 0.05, saccharin preference ratio WT vs.
LO ∗p< 0.05).
VMAT2 Deficient Mice Do not Present
Evidence of Depressive-Like Behavior
To determine the existence of depressive-like behavior in LO
mice, we subjected them and their WT controls to the forced
swimming test (Figure 4). Using an automated recording system,
we measured the time spent immobile of each animal during a
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FIGURE 2 | Impaired nesting in VMAT2 deficient mice. Nesting performance was assessed by measuring the percentage of the Nestlet torn (A–C) and the nest
rating (score 1–5; D–F) in both LO mice and their WT controls. No differences were found in the whole (n = 19 WT, n = 15 LO; A,D) or inactive (n = 9–10 WT,
n = 5–7 LO; C,F) nester populations. However, both the % of Nestlet torn and the nest rating scores were significantly reduced in the LO group within the active
nesters population, as compared to their WT controls (percentage of Nestlet torn: n = 9 WT, n = 8 LO, ∗p < 0.05, (B) nest ratings: n = 10 WT, n = 10 LO,
∗∗p < 0.01, E). Bars indicate the mean of the groups and error bars indicate the S.E.M.
forced swimming session of 4 min. Our results showed similar
immobility times in LO and WT mice in the whole and the
two sub-populations analyzed (2-sided, unpaired t-tests; time of
immobility WT vs. LO p> 0.05).
DISCUSSION
In this study we aimed at evaluating the usefulness of
VMAT2 deficient mice as a tool to study apathy-like symptoms
(i.e., reduction in goal-directed, reward-related behaviors) in the
context of PD.
Although the pathological mechanisms of apathy are poorly
understood and need further elucidation (Santangelo et al., 2013;
Pagonabarraga et al., 2015), impairment in the dopaminergic
pathways are assumed to underlie both PD and apathy (Pedersen
et al., 2009a,b; Zahodne et al., 2012). Thus, animal models
mimicking PD pathology are of special interest in the study of
apathy. However, since apathy and depression are closely related
but yet different constructs, depression can be a confounder
in the study of apathy, especially in the context of PD,
where depression and apathy are both common comorbid
disorders (van Reekum et al., 2005). Thus, animal models
of PD presenting apathy-like symptoms in the absence of
depressive-like symptoms are desirable for the study of apathy’s
underlying processes and the development of specific treatments.
We evaluated the performance of 12 months old VMAT2 LO
mice in four behavioral tests, namely the burrowing test, nest
building test, saccharin preference test and forced swimming
test, and observed a significantly lowered performance in
LO mice in the first three behavioral tasks. The reduced
burrowing and nest building activities suggest impairment
in goal-directed, motivated behaviors in VMAT2 LO mice.
Burrowing likely constitutes a motivation-dependent behavioral
need (Sherwin et al., 2004) and nesting, as well as burrowing
behavior, are suggested to represent a murine form of the
ability to perform goal-directed ‘‘activities of daily living’’
(Deacon, 2009; Jirkof, 2014). These impairments might be
akin to human apathetic patients, who show drastically
reduced self-generated voluntary and purposeful behaviors (Levy
and Dubois, 2006), and dysfunction in motivation (Robert
et al., 2009). The saccharin preference test might also reflect
apathetic symptoms in VMAT2 LO mice by reflecting the
reduced preference for sweet solutions as a consequence of
impaired mesolimbic dopaminergic reward pathways. Mice
treated with dopamine receptor antagonists or injected with
6-hydroxydopamine (6-OHDA) into the nucleus accumbens
exhibit significantly reduced preference for sweet solutions
(Muscat and Willner, 1989; Malatynska et al., 2012). Vice
versa, the restoration of dopamine production in the nucleus
accumbens of dopamine-deficient mice could normalize the
preference for sweet solutions (Szczypka et al., 2001). Lesions
of the ventral tegmental area in mice also entailed diminished
sucrose preference (Martínez-Hernández et al., 2006), and the
consumption of sucrose in rats has been shown to induce the
release of dopamine and to correlate with its concentration in
the ventral striatum (Brenes and Fornaguera, 2008; de Araujo
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FIGURE 3 | Reduced preference for a sweetened solution in VMAT2 deficient mice. The amount of water (A) saccharin (B) and total liquid (C) intake was
determined by the saccharin preference test. In addition, we calculated (D) the saccharin preference ratio as the intake of (saccharin/(saccharin + water)). There was
no difference in water intake between LO and WT mice. However, saccharin and total liquid intake (driven by the reduction in saccharin intake) was significantly
reduced in LO mice, as compared to their WT controls (saccharin intake ∗∗p < 0.01, total liquid intake ∗p < 0.05). A significantly reduced saccharin preference ratio
was also driven by the pronounced reduction in saccharin consumption (p < 0.05). All measures were normalized by the respective body weight to control for the
lower weight of the VMAT2 mutants. Bars indicate the mean of the groups and error bars indicate the S.E.M.
et al., 2008). The circuit of dopaminergic projections from
neurons of the ventral tegmental area to the ventral striatum,
more precisely to the nucleus accumbens, is indeed, the best
characterized reward circuit in the rodent brain (Russo and
Nestler, 2013). However, dopamine is not the only afflicted
neurotransmitter in apathy, neither in PD nor in VMAT2 LO
mice. In VMAT2 LO mice norepinephrine concentrations are
also drastically reduced, illustrated by progressive degeneration
in the locus coeruleus, that even preceded degeneration in the
substantia nigra pars compacta (Taylor et al., 2014). A recent
study revealed that at the age of 4–6 months VMAT2 LO mice
also exhibited dramatically reduced serotonin release capacity
(Alter et al., 2015). Thus, reducing the VMAT2 LO model
primary to a dopaminergic deficiency is oversimplifying, and
the same criticism can be applied to the hypothesis of apathy
being mainly caused by dopaminergic dysfunction. Apathy is a
complex syndrome that is not limited to dopaminergic activity,
as serotonergic, cholinergic and noradrenergic neurotransmitter
systems are known to be involved in the same circuits that are
affected in PD (Pagonabarraga et al., 2015).
FIGURE 4 | Normal immobility time in VMAT2 deficient mice. The time of immobility during a forced swimming session of 4 min in WT and LO mice indicated
no significant differences between both genotypes in the whole and the two sub-populations analyzed. Two-sided, t test; (A) whole population: p = 0.896;
(B) proficient swimmers: p = 0.742; (C) poor swimmers: p = 0.777. Bars indicate the means of the groups and error bars indicate the S.E.M.
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On the other hand, our forced swimming test result showed
that 12-months old VMAT2 LO and WT mice do not differ
in the time spent immobile during the 4 min of the test,
indicating a possible lack of depressive-like symptoms in the
VMAT2 mutants. In addition, own results in the tail suspension
test indicate a similar finding, with unchanged time spent
immobile in the mutants as compared to controls (data not
shown). These findings are conflicting with previously reported
data from VMAT2 LO and HET mice, showing increased
immobility times in the forced swimming test (Fukui et al., 2007;
Taylor et al., 2009). Specifically, VMAT2 HET mice showed
increased immobility times at the age of 3–5months (Fukui et al.,
2007), whereas the VMAT2 LO mice did not show increased
immobility times at 4–6 months, but only later at the age of
12–15months (Taylor et al., 2009). Despite these conflicting data,
a series of aspects confirm the validity of our findings. First, the
previously characterized VMAT2 HET mice differ in age and
genotype from the LOmice tested here and, therefore, our results
cannot be directly contrasted to those of Fukui et al. (2007).
Second and in regard to the observations of Taylor et al. (2009),
it can be speculated that depressive-like symptoms could start
evidencing only after 12 months of age and therefore manifest
later on in increased immobility times. Finally, our sample
sizes were significantly larger than in the previous VMAT2 LO
characterization, providing increased validity to our results.
Dysfunctions of the nigrostriatal, mesolimbic and
mesocortical dopaminergic pathways are suggested to play
an important role in the manifestation of apathy (Thobois
et al., 2010; Santangelo et al., 2013). Indeed, several findings
substantiate the importance of dopaminergic activity in the
pathology of apathy. Dopaminergic treatment seems to decrease
apathy in early stages of PD (Santangelo et al., 2014) and the
severity of apathy changes in regard to the dopaminergic ‘‘on’’
and ‘‘off’’ treatment states (Lhommée et al., 2012; Castrioto et al.,
2014). Since VMAT2 deficient mice are vastly impaired in their
dopaminergic neurotransmission, it is conceivable that they
would manifest symptoms of apathy.
The main limitation of our study is the missing longitudinal
dimension in our experiments. Evaluating the progression of
apathetic symptoms throughout the life-span of the mice, as
well as its temporal relation with depressive-like symptoms
would provide a more profound insight regarding the temporal
window of apathy-based studies and the development of specific
treatment options for each condition. An additional drawback
of our design is that the applied behavioral tests may not be
entirely specific for one symptom or another. In this line, the
independence of apathy from depression has been matter of
intense debate, as apathy has classically been considered as a core
feature of depression (Kirsch-Darrow et al., 2006; Santangelo
et al., 2013) andmany definitions of depression comprise features
of apathy (Cummings et al., 2015). Moreover, we explore apathy
in an animal model of dopaminergic deficiency rather than
implementing a specific test for apathy, which remains largely
missing in the field. Thus, relying on behavioral tests that
accurately measure the effect of dopaminergic dysfunction over
goal-directed and reward-related behaviors in the context of PD,
appears as a risky but promising strategy in the study of pure
apathy.
In summary, 12 months old VMAT2 deficient mice likely
do not express a depressive-like phenotype but rather show
behavioral signs of apathy that might be related to dopaminergic
dysfunction. Future research should validate our preliminary
results and address potential modulatory effects of dopaminergic
treatment on the performance in the burrowing, nest building
and saccharin preference tests, and closely relate the development
of the apathetic phenotype to the underlying neurochemical
changes in VMAT2 deficient mice’s brains.
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